Thunder Bay Regional Health Sciences Centre

The trials here

What the 13 trials at this site are about, from their registry records.

Conditions

• Bladder cancer3 trials
• Prostate cancer3 trials
• Atrial fibrillation1 trial
• Childhood cancers1 trial
• Colorectal cancer1 trial
• Coronary artery disease1 trial
• Heart failure1 trial
• Metastatic breast cancer1 trial
• Multiple myeloma1 trial
• Stroke1 trial

Phase

• Phase 33 trials
• Phase 42 trials
• Phase 21 trial

Status

• Active, not recruiting5 trials
• Completed4 trials
• Recruiting2 trials
• Not yet recruiting1 trial
• Terminated1 trial

Lead sponsor

• Population Health Research Institute3 trials
• Canadian Cancer Trials Group2 trials
• Ottawa Hospital Research Institute2 trials
• Hoffmann-La Roche1 trial
• London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1 trial
• and 4 more

Running trials

• Recruiting

  Enhancing the Patient Journey to Clinical Trial Enrolment With Navigation to Optimize Accrual

  NCT06905002· Windsor Regional Hospital· Source

  Contact: Nicole Laferriere, MD

• Recruiting

  Fixed Duration vs Continuous Anti-CD38 Antibody Therapy Among Transplant Ineligible Older Adults With Newly-Diagnosed Multiple Myeloma

  NCT06182774· Phase 3· Canadian Cancer Trials Group· Source

  Contact: Nicole Laferriere

• Active, not recruiting

  A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)

  NCT06065748· Phase 3· Hoffmann-La Roche· Source

• Active, not recruiting

  Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease

  NCT05701358· Population Health Research Institute· Source

• Recruiting

  VIrtual Care To Improve Outcomes and RecoverY From Heart Failure Hospitalization

  NCT05724433· Population Health Research Institute· Source

  Contact: Vahid Akbari

• Active, not recruiting

  Comparing Continuation or De-escalation of Bone Modifying Agents (BMA) in Patients Treated for Over 2 Years for Bone Metastases From Either Breast or Castration-resistant Prostate Cancer

  NCT04549207· Phase 4· Ottawa Hospital Research Institute· Source

• Active, not recruiting

  Trimodality Therapy With/Out Durvalumab to Treat Patients With Muscle-Invasive Bladder Cancer

  NCT03768570· Phase 2· Canadian Cancer Trials Group· Source

• Active, not recruiting

  Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer

  NCT02446405· Phase 3· University of Sydney· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers1 recruiting
• Heart failure1 recruiting
• Multiple myeloma1 recruiting

Closed trials

• Terminated

  TFL vs MOSES Holmium Laser in the En-bloc Resection of Bladder Tumors

  NCT06373419· Thunder Bay Regional Health Research Institute· Source

• Completed

  IBD Neoplasia Surveillance RCT

  NCT05809999· Ottawa Hospital Research Institute· Source

• Completed

  EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)

  NCT03950076· Phase 4· Population Health Research Institute· Source

• Completed

  PSMA-PET Registry for Recurrent Prostate Cancer

  NCT03718260· London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's· Source

• Completed

  Impact of Positron Emission Tomography (PET) Imaging in Muscle-invasive Urothelial Carcinoma of the Bladder Staging

  NCT02462239· Ontario Clinical Oncology Group (OCOG)· Source